Characteristics | All cases | APC7 positive | APC7 negative | P a (significance) |
---|---|---|---|---|
All carcinomas | 108 (100%) | 68 (63.0%) | 40 (37.0%) | Â |
Tumor size | Â | Â | Â | 0.8180 (NSb) |
Small (<5 cm) | 81 (100%) | 51 (63.0%) | 30 (37.0%) | Â |
Large (≥ 5 cm) | 27 (100%) | 17 (63.0%) | 10 (37.0%) |  |
Metastasis | Â | Â | Â | 0.9703 (NS) |
Negative | 47 (100%) | 29 (61.7%) | 18 (38.3%) | Â |
Positive | 61 (100%) | 39 (63.9%) | 22 (36.1%) | Â |
Clinical stage | Â | Â | Â | 0.2798 (NS) |
I | 19 (100%) | 15 (78.9%) | 4 (21.1%) | Â |
II | 65 (100%) | 39 (60.0%) | 26 (40.0%) | Â |
III | 24 (100%) | 14 (58.3%) | 10 (41.7%) | Â |
ERc | Â | Â | Â | 0.1031 (NS) |
Positive | 51 (100%) | 36 (70.6%) | 15 (29.4%) | Â |
Negative | 51 (100%) | 27 (52.9%) | 24 (47.1%) | Â |
Histologic grade | Â | Â | Â | 0.001 |
I | 33 (100%) | 28 (84.8%) | 5 (15.2%) | Â |
II | 55 (100%) | 33 (60.0%) | 22 (40.0%) | Â |
III | 20 (100%) | 7 (35.0%) | 13 (65.0%) | Â |
Nuclear grade | Â | Â | Â | 0.0090 |
1 | 6 (100%) | 6 (100%) | 0 (0%) | Â |
2 | 87 (100%) | 57 (65.5%) | 30 (34.5%) | Â |
3 | 15 (100%) | 5 (33.3%) | 10 (66.7%) | Â |
Mitotic number (n/10 hpfd) | Â | Â | Â | 0.0016 |
<10 | 49 (100%) | 37 (75.5%) | 12 (24.5%) | Â |
10–19 | 41 (100%) | 26 (63.4%) | 15 (36.6%) |  |
≥20 | 18 (100%) | 5 (27.8%) | 13 (72.2%) |  |
Ki-67 labeling indexe | Â | Â | Â | 0.0078 |
L (<25.5) | 63 (100%) | 58 (76.2%) | 15 (23.8%) | Â |
H (≥ 25.5) | 41 (100%) | 20 (48.8%) | 21 (51.2%) |  |
DNA ploidyf | Â | Â | Â | 0.0095 |
Diploidy | 17 (100%) | 16 (94.1%) | 1 (5.9%) | Â |
Aneuploidy | 77 (100%) | 44 (57.1%) | 33 (42.9%) | Â |